Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity

Vaccine

Volumn 27, Issue 43, 2009, Pages 6080-6087

  Khan, Sheema ^a   Malik, Fayaz ^a   Suri, Krishan A ^a   Singh, Jaswant ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Co stimulatory molecules; Freund's adjuvant; Immunoglobulin isotypes; Integrins; Th1 Th2 cytokines; Withania somnifera

Indexed keywords

2,3 DIHYDRO 3 SULPHONILE WITHANONE; ASHWAGANDHA EXTRACT; B7 ANTIGEN; CD11B ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CONCANAVALIN A; FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; INTEGRIN; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE SURFACE MARKER; OVALBUMIN; PLANT EXTRACT; UNCLASSIFIED DRUG; WITHANOLIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; EMULSION; FEMALE; FLOW CYTOMETRY; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; INFECTION; INTROSPECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; SPLEEN CELL; STANDARDIZATION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; UPREGULATION; WITHANIA SOMNIFERA;

ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOLOGIC FACTORS; INTEGRINS; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; SPLEEN; TH1 CELLS; UP-REGULATION; WITHANIA; WITHANOLIDES;

EID: 70349285962     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.07.011     Document Type: Article

References (22)

1. Malik F., Singh J., Khajuria A., Suri K., Satti N., Singh S., et al. A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up-regulation of Th1-dominant polarization in BALB/c mice. Life Sci 80 (2007) 525-1538
2. Mishra L., Singh B., and Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Altern Med Rev 5 (2000) 334-346
3. Kaul M., Kumar A., and Sharma A. Reproductive biology of Withania somnifera (L.) Dunal. Curr Sci 88 (2005) 1375-1377
4. Malik F., Kumar A., Bhushan S., Khan S., Bhatia A., Suri K., et al. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis 12 (2007) 2115-2133
5. Matusuda H., Murakami T., Kishi A., and Yoshikawa M. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera Dunal. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg Med Chem 9 (2001) 1499-1507
6. Malik F., Kumar A., Bhushan S., Mondhe D., Pal H., Sharma R., et al. Immune modulation and apoptosis induction: two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera. Eur J Cancer 45 (2009) 1494-1509
7. Kuboyama T., Tohda C., and Komatsu K. Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharm 144 (2005) 961-971
8. Mohan R., Hammers H., Bargagna M., Zhan X., Herbstritt C., Ruiz A., et al. Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7 (2004) 115-122
9. Bretsche P., Ismail N., Menon J., Power C., Uzonna J., and Wei G. Vaccination against and treatment of tuberculosis, the leishmaniases and AIDS: perspectives from basic immunology and immunity to chronic intracellular infections. Cell Mol Life Sci 58 (2001) 1879-1896
10. Wabl M.R., Forni L., and Loor F. Switch in immunoglobulin class production observed in single clones of committed lymphocytes. Science 199 (1978) 1078-1080
11. Nijnik A., Dawson S., Crockford L.T., Woodbine L., Visetnoi S., Bennett S., et al. Impaired lymphocyte development and antibody class switching and increased malignancy in a murine model of DNA ligase IV syndrome. J Clin Invest 119 (2009) 1696-1705
12. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8 (2003) 223-246
13. Gerloni M., and Zanetti M. CD4 T cells in tumor immunity. Semin Immunopathol 27 (2005) 37-48
14. + cells. Drug Safe 21 (1999) 91-100
15. Kuchroo V., Das M., Brown J., Ranger A., Zamvil S., Sobel R., et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 77 (1995) 707-718
16. Lenschow D., Ho S., Sattar H., Rhee L., Gray G., Nabavi N., et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the non-obese diabetic mouse. J Exp Med 77 (1995) 1145-1155
17. Girvin A., Dal Canto M., Rhee L., Salomon B., Sharpe A., Bluestone J., et al. Critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. J Immunol 164 (2000) 136-143
18. Lub M., Van Kooyk Y., and Figdor C. Ins and outs of LFA-1. Immunol. Today 16 (1995) 479
19. Watts T., and Benedette M. T cell costimulatory molecules other than CD28. Curr Opin Immunol 11 (1999) 286
20. Azar R., McKay R., Kierman F., Seecharran B., Feng Y., Fram D., et al. Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 80 (1997) 1476-1478
21. Stewart M., Thiel M., and Hogg N. Leukocyte integrins. Curr Opin Cell Biol 7 (1995) 690-696
22. Misra L., Lal P., Sangwan R., Sangwan N., Uniyal G., and Tuli R. Unusually sulfated and oxygenated steroids from Withania somnifera. Phytochemistry 66 (2005) 2702-2707